Additionally, through promoting the secretion of tumor necrosis factor-α (TNF-α) and interferon γ (IFN-γ), metformin could significantly boost the anti-tumor activity of CD8+ T cells to indirectly retard tumor progression [11]. Here, CD8A is linked to neoplasm.